GLP-1 SM

GLP-1 SM is a glucagon-like peptide-1 (GLP-1) receptor agonist studied for its role in regulating blood glucose, appetite, and body weight. By mimicking the effects of GLP-1, Semaglutide enhances insulin secretion, suppresses glucagon release, and slows gastric emptying, making it a valuable research tool for studies on obesity, diabetes, and metabolic disorders.

Key Benefits:

• Supports research on weight management through appetite regulation and caloric reduction.
• Aids studies on glucose control and insulin sensitivity in metabolic health.
• Contributes to investigations on cardiovascular risk reduction.
• Explored for roles in obesity-related conditions and long-term metabolic balance.

Purity Assurance

Every peptide we offer undergoes rigorous testing to ensure research-grade purity. Our claims are backed by regular in-house & third-party batch testing, assuring the highest quality standards.

This product is for research purposes only. It is intended exclusively for in vitro testing and laboratory experiments. All information provided on this website is for educational purposes and is not intended for human or animal use. The introduction of this product into the body, whether by ingestion, injection, or any other means, is strictly prohibited by law. Only licensed and qualified professionals should handle this product. It is not a drug, food, or cosmetic and must not be mislabeled, misused, or marketed as such.